The Discounted Cash Flow (DCF) valuation of AtriCure Inc (ATRC) is (18.91) USD. With the latest stock price at 30.72 USD, the upside of AtriCure Inc based on DCF is -161.6%.
Based on the latest price of 30.72 USD and our DCF valuation, AtriCure Inc (ATRC) is a sell. selling AtriCure stocks now will result in a potential gain of 161.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 10.6% | 8.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (48.21) - (12.02) | (18.91) |
| Upside | -256.9% - -139.1% | -161.6% |